Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-27

Clinical Trial Update: The Effect of Adding Nalbuphine to Intrathecal Morphine on Analgesic Efficacy and Side Effects After Cesarean Section [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether adding nalbuphine to intrathecal morphine improves analgesic efficacy and side effects after cesarean section.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intrathecal morphine (morphine)
  • Nalbuphine (nalbuphine)

Snippet

Sponsor: Abdelrady S Ibrahim, MD | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED